Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

With readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false already in annotations, the description goes well beyond by disclosing concrete runtime behavior: returns identifiers labelled by source, explicitly lists unresolved identifiers under 'unresolved' instead of omitting them, returns 'figi_candidates' when a name matches multiple instruments, gracefully degrades when GLEIF/OpenFIGI are unavailable, and cascades through multiple endpoints internally. This gives strong transparency into input-to-output behavior with no contradiction against annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense and long, but nearly every clause adds necessary behavioral or parameter context. It is front-loaded with user-phrase examples and the 'Use FIRST' directive, then organized by supported type with explicit caveats. Some redundancy exists with the schema's value description (e.g., 'ENTITY NAME ONLY' appears in both), and the parenthetical-heavy style makes it slightly harder to scan, but the structure is logical and no sentence is ornamental.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, so the description must carry the burden of explaining return behavior, and it does so in detail: CIK/ticker/company_name from EDGAR, LEI and ownership from GLEIF, FIGI from OpenFIGI, RxCUI/ingredient/brand from RxNorm, plus `unresolved` and `figi_candidates` cases. It also covers failure behavior, accepted identifier formats, and the practical benefit of replacing multiple manual lookups. For a tool with this much cross-source complexity, the description is remarkably complete.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already describes both parameters and reaches 100% description coverage, but the description adds materially beyond the schema: it introduces ISIN as a valid company input, clarifies FIGI lookup behavior for non-ticker instruments, explains the 'ENTITY NAME ONLY' requirement and issuer-exact matching for bonds, and details the `figi_candidates` disambiguation path. These are not just restatements of the schema; they resolve real decision points an agent would face when populating `type` and `value`.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description names a clear verb ('resolve'), a specific resource ('user-spoken NAME to canonical/official identifiers'), and explicitly frames the tool as the input provider for 'other tools require as input.' It also enumerates two distinct entity types, company and drug, and differentiates this resolver from sibling lookup/analysis tools through statements like 'Use FIRST whenever you have a name but need an ID.' This is far beyond a tautology and leaves minimal ambiguity about what the tool does.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit trigger conditions: 'Use FIRST whenever you have a name but need an ID' and provides detailed scoping for company vs drug lookups, including edge cases like non-equity instruments and ISIN-to-LEI resolution. It does not explicitly name sibling alternatives or state 'do not use when...', but the strong 'use first whenever' guidance plus the input-format details gives an agent clear situational direction.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.1/5.0
Disambiguation4/5

Most tools are distinct (event search, subscriptions, memory, Polymarket arbitrage, data lookups), but ai_visibility_check, scan_competitor_ai_presence, bet_research, polymarket_edges, and polymarket_arbitrage have overlapping purposes around competitive research and prediction-market edge-finding. The detailed descriptions disambiguate them, though an agent could confuse polymarket_edges with polymarket_arbitrage.

Naming Consistency4/5

Tool names are mostly descriptive and consistent: search_events, event, categories, tags are aligned; ask_pipeworx, compare_entities, entity_profile follow a similar pattern. However, polymarket_* tools have an odd mix of `polymarket_arbitrage`, `polymarket_fill_risk`, and `polymarket_edge_tracker`, and discover_tools/recent_alerts/recent_changes are consistent, mostly. Naming is quite consistent overall with minor deviations.

Tool Count3/5

At 35 tools, the count is heavier than typical MCP servers, but it reflects a broad service (Funcheap data + Pipeworx data platform + pred markets). Still, plenty of tools serve the same primary purpose (polymarket_, ask_pipeworx variants) so some pruning would improve the surface.

Completeness4/5

The surface appears complete for its domain: search/retrieve events, category/tag navigation, memory, subscriptions (create/list/cancel/pull), data lookups, entity resolution, comparisons, profiles, edge scanning, and feedback. Minor gaps include no direct 'update' on events (but events are static), and no pricing fetch tool separate from event text, though body text covers it.